Field Director, Hematology & Oncology, Medical Affairs

Recordati•Bridgewater, NJ

5d•$205,000 - $270,000

About The Position

The Field Director, Hematology & Oncology, Medical Affairs is responsible for the effectiveness and ongoing activities of the Medical Science Liaison (MSL) team across North America. The role ensures strong Key Opinion Leader (KOL) identification and mapping, territory alignment, and effective goals and measures for KOL engagement. It also ensures that MSLs are trained in scientific knowledge and communication skills, and that team priorities and activities are adjusted as needed to address RRD’s needs. The Field Director oversees recruiting, onboarding, training, performance metrics, and personnel matters for MSLs. The role develops and implements RRD’s KOL engagement strategy, aligns territories, sustains KOL engagement during staffing gaps, and ensures that insights from KOL interactions are collected, summarized, and shared appropriately. It also serves as the Medical Affairs point person supporting Commercial’s speaker programs by providing speakers with MSL resources and assistance answering questions. The position contributes to RRD’s Medical Strategy, coordinates cross-functional support for advocacy engagement, and manages Medical Affairs engagement at congresses and meetings. It also contributes to scientific data evolution planning by identifying data gaps and highlighting those expected to be addressed by the current clinical development program. This is a field-based role requiring domestic travel up to 70%. The position operates in a professional office environment when on-site, with occasional travel to meetings, including out of province, on weekends and at night.

Requirements

Strong scientific background and 5 or more years of experience in the pharmaceutical or biotechnology industry managing field-based medical teams.
Experience reporting field-based medical metrics and developing innovative metrics to articulate the impact of the medical organization.
Extensive pharmaceutical experience and good knowledge of applicable regulations.
Proficiency in Microsoft Office, basic computer and typing skills, and tools or systems for managing clinical trials.
Strong written and verbal English communication and presentation skills.
Ability to resolve conflicts, collaborate with stakeholders with varying viewpoints, influence with and without authority, and negotiate.
Relationship management skills with multiple internal and external stakeholders, including KOLs, networks, Patient Association Groups (PAGs), and CROs.
Valid driver’s license and passport.
Ability to travel domestically up to 70%, travel by car and train or plane, and fly via a commercial air carrier.

Nice To Haves

Advanced scientific degree (M.D., D.O., Ph.D., or Pharm.D.) in Medical or Biological Sciences.
Experience in rare diseases.
Experience in hematology and oncology.

Responsibilities

Lead the Medical Science Liaison field team, including recruiting and hiring, onboarding, and ongoing scientific and communication skills training.
Establish compliant MSL performance metrics, track them, and report on them.
Manage personnel issues to maximize field engagement and minimize disruptions.
Develop and implement RRD’s KOL engagement strategy in alignment with the Medical Strategy.
Identify and prioritize KOLs, establish engagement expectations, and align MSL territories to ensure consistent engagement.
Manage KOL engagement during temporary or longer-term MSL staffing gaps.
Ensure MSLs gather and report insights from KOL interactions and that insights are summarized and appropriately shared across RRD.
Serve as the Medical Affairs point person for Commercial’s speaker programs, providing speakers with MSL resources for training and help answering questions.
Contribute to RRD’s overall Medical Strategy with other functions, obtain feedback, and promote alignment throughout RRD.
Coordinate cross-functional and MSL support for RRD’s advocacy engagement activities.
Manage engagement at congresses and meetings, including prioritization, resource deployment, KOL engagement planning and execution, and appropriate opportunities for senior leaders to interact with KOLs.
Contribute to scientific data evolution plans by identifying gaps in current RRD data and highlighting gaps expected to be addressed by the current clinical development program.